• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆羧肽酶B对纤溶酶原功能的体内调节

In vivo regulation of plasminogen function by plasma carboxypeptidase B.

作者信息

Swaisgood Carmen M, Schmitt Detlef, Eaton Dan, Plow Edward F

机构信息

Department of Molecular Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

出版信息

J Clin Invest. 2002 Nov;110(9):1275-82. doi: 10.1172/JCI15082.

DOI:10.1172/JCI15082
PMID:12417566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC151605/
Abstract

The major functions of plasminogen (Plg) in fibrinolysis and cell migration depend on its binding to carboxy-terminal lysyl residues. The ability of plasma carboxypeptidase B (pCPB) to remove these residues suggests that it may act as a suppressor of these Plg functions. To evaluate this role of pCPB in vivo, homozygote pCPB-deficient mice were generated by homologous recombination, and the resulting pCPB(-/-) mice, which were viable and healthy, were mated to Plg(-/-) mice. Plg(+/-) mice show intermediate levels of fibrinolysis and cell migration compared with Plg wild-type and deficient mice, reflecting the intermediate levels of the Plg antigen in their plasma. Differences in Plg-dependent functions between pCPB(+/+), pCPB(+/-), and pCPB(-/-) mice were then analyzed in a Plg(+/-) background. In a pulmonary clot lysis model, fibrinolysis was significantly increased in mice with partial (pCPB(+/-)) or total absence (pCPB(-/-)) of pCPB compared with their wild-type counterparts (pCPB(+/+)). In a thioglycollate model of peritoneal inflammation, leukocyte migration at 72 hours increased significantly in Plg(+/-)/pCPB(+/-) and Plg(+/-)/pCPB(-/-) compared with their wild-type counterparts. These studies demonstrate a definitive role of pCPB as a modulator of the pivotal functions of Plg in fibrinolysis and cell migration in vivo.

摘要

纤溶酶原(Plg)在纤维蛋白溶解和细胞迁移中的主要功能取决于其与羧基末端赖氨酰残基的结合。血浆羧肽酶B(pCPB)去除这些残基的能力表明,它可能作为这些Plg功能的抑制剂。为了评估pCPB在体内的这一作用,通过同源重组产生了纯合子pCPB缺陷小鼠,并将存活且健康的所得pCPB(-/-)小鼠与Plg(-/-)小鼠交配。与Plg野生型和缺陷型小鼠相比,Plg(+/-)小鼠的纤维蛋白溶解和细胞迁移水平处于中间状态,这反映了它们血浆中Plg抗原的中间水平。然后在Plg(+/-)背景下分析了pCPB(+/+)、pCPB(+/-)和pCPB(-/-)小鼠之间Plg依赖性功能的差异。在肺血栓溶解模型中,与野生型对应物(pCPB(+/+))相比,部分(pCPB(+/-))或完全缺乏(pCPB(-/-))pCPB的小鼠纤维蛋白溶解显著增加。在硫代乙醇酸盐诱导的腹膜炎模型中,与野生型对应物相比,Plg(+/-)/pCPB(+/-)和Plg(+/-)/pCPB(-/-)小鼠在72小时时白细胞迁移显著增加。这些研究证明了pCPB在体内作为Plg在纤维蛋白溶解和细胞迁移中的关键功能调节剂的明确作用。

相似文献

1
In vivo regulation of plasminogen function by plasma carboxypeptidase B.血浆羧肽酶B对纤溶酶原功能的体内调节
J Clin Invest. 2002 Nov;110(9):1275-82. doi: 10.1172/JCI15082.
2
On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B.关于血浆羧肽酶B抗纤维蛋白溶解活性的机制
J Biol Chem. 1997 May 30;272(22):14477-82. doi: 10.1074/jbc.272.22.14477.
3
Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B.人血浆中的血栓调节蛋白通过加速凝血酶依赖性的血浆前羧肽酶B激活来抑制纤维蛋白溶解。
Thromb Haemost. 1998 Feb;79(2):371-7.
4
Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice.纤溶酶原基因缺失对小鼠血栓形成、生长及健康状况的影响。
Circulation. 1995 Nov 1;92(9):2585-93. doi: 10.1161/01.cir.92.9.2585.
5
Plasma carboxypeptidases as regulators of the plasminogen system.血浆羧肽酶作为纤溶酶原系统的调节剂。
J Clin Invest. 1995 Nov;96(5):2534-8. doi: 10.1172/JCI118315.
6
Activation and characterization of procarboxypeptidase B from human plasma.人血浆中羧肽酶原B的激活与特性研究
Biochemistry. 1995 May 2;34(17):5811-6. doi: 10.1021/bi00017a012.
7
In vivo plasminogen deficiency reduces fat accumulation.体内纤溶酶原缺乏会减少脂肪堆积。
Thromb Haemost. 2002 Jun;87(6):1011-9.
8
Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma.从人血浆中分离、分子克隆及鉴定一种新型羧肽酶B
J Biol Chem. 1991 Nov 15;266(32):21833-8.
9
Growth and behavioral development in plasminogen gene-targeted mice.纤溶酶原基因靶向小鼠的生长与行为发育
Growth Dev Aging. 1999 Spring-Summer;63(1-2):13-32.
10
Plasminogen deficiency attenuates postnatal erythropoiesis in male C57BL/6 mice through decreased activity of the LH-testosterone axis.纤溶酶原缺乏通过降低 LH-睾丸酮轴的活性来减弱雄性 C57BL/6 小鼠的出生后红细胞生成。
Exp Hematol. 2012 Feb;40(2):143-54. doi: 10.1016/j.exphem.2011.10.008. Epub 2011 Nov 3.

引用本文的文献

1
Identification of heparin interaction sites on thrombin-activatable fibrinolysis inhibitor that modulate plasmin-mediated activation, thermal stability, and antifibrinolytic potential.鉴定凝血酶激活的纤维蛋白溶解抑制剂上的肝素相互作用位点,这些位点可调节纤溶酶介导的激活、热稳定性和抗纤维蛋白溶解潜力。
Res Pract Thromb Haemost. 2024 May 27;8(4):102459. doi: 10.1016/j.rpth.2024.102459. eCollection 2024 May.
2
Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?羧肽酶B1是导管原位癌的预后标志物吗?
Cancers (Basel). 2021 Apr 6;13(7):1726. doi: 10.3390/cancers13071726.
3
Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review.凝血酶激活的纤溶抑制物(TAFI):更新的叙述性综述。
Int J Mol Sci. 2021 Apr 1;22(7):3670. doi: 10.3390/ijms22073670.
4
Plasminogen Receptors and Fibrinolysis.纤溶酶原受体与纤维蛋白溶解。
Int J Mol Sci. 2021 Feb 8;22(4):1712. doi: 10.3390/ijms22041712.
5
Functions of the plasminogen receptor Plg-R.纤溶酶原受体Plg-R的功能
J Thromb Haemost. 2020 Oct;18(10):2468-2481. doi: 10.1111/jth.15014. Epub 2020 Aug 19.
6
Plasminogen and the Plasminogen Receptor, Plg-R, Regulate Macrophage Phenotypic, and Functional Changes.纤溶酶原及其受体(Plg-R)调节巨噬细胞表型和功能变化。
Front Immunol. 2019 Jun 28;10:1458. doi: 10.3389/fimmu.2019.01458. eCollection 2019.
7
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.全基因组关联研究常见和罕见遗传变异与循环凝血酶激活的纤维蛋白溶解抑制剂的关系。
Thromb Haemost. 2018 Feb;118(2):298-308. doi: 10.1160/TH17-04-0249. Epub 2018 Jan 29.
8
Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.活化的凝血酶激活的纤溶抑制因子减弱内皮细胞的血管生成潜能:与乳腺肿瘤微环境的潜在相关性。
Clin Exp Metastasis. 2017 Feb;34(2):155-169. doi: 10.1007/s10585-017-9837-y. Epub 2017 Jan 25.
9
Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.解除肺栓塞中纤维蛋白溶解系统的制动:纤溶酶原激活和α2-抗纤溶酶失活的独特作用
Circulation. 2017 Mar 14;135(11):1011-1020. doi: 10.1161/CIRCULATIONAHA.116.024421. Epub 2016 Dec 27.
10
Deficiency of plasminogen receptor, Plg-R , causes defects in plasminogen binding and inflammatory macrophage recruitment in vivo.纤溶酶原受体(Plg-R)缺乏会导致体内纤溶酶原结合及炎性巨噬细胞募集缺陷。
J Thromb Haemost. 2017 Jan;15(1):155-162. doi: 10.1111/jth.13532. Epub 2016 Nov 28.

本文引用的文献

1
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life.凝血酶激活的纤维蛋白溶解抑制剂(TAFI)缺乏与小鼠的生命相容。
J Clin Invest. 2002 Jan;109(1):101-10. doi: 10.1172/JCI12119.
2
Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms.血浆凝血酶激活的纤溶抑制物(TAFI)抗原水平与TAFI基因多态性的联合分离-连锁分析
Hum Genet. 2001 Aug;109(2):191-7. doi: 10.1007/s004390100558.
3
Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.凝血酶激活的纤溶抑制物(TAFI)基因5'-非翻译区多态性的鉴定:与血浆TAFI水平及静脉血栓形成风险的关系
Haematologica. 2001 May;86(5):510-7.
4
Regulation of plasminogen binding to neutrophils.纤溶酶原与中性粒细胞结合的调节。
Blood. 2001 Feb 15;97(4):1070-8. doi: 10.1182/blood.v97.4.1070.
5
Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.凝血酶激活的纤维蛋白溶解抑制剂通过降低(DD)E对组织纤溶酶原激活物的亲和力,减弱(DD)E介导的纤溶酶原激活刺激。这是增强组织纤溶酶原激活物纤维蛋白特异性的一种潜在机制。
J Biol Chem. 2000 Nov 24;275(47):36612-20. doi: 10.1074/jbc.M005483200.
6
Plasma TAFI antigen variations in healthy subjects.健康受试者血浆中凝血酶激活的纤溶抑制物抗原的变化
Thromb Haemost. 2000 Jun;83(6):902-5.
7
The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.纤溶系统成分缺陷小鼠中博来霉素诱导的肺纤维化的发展
Am J Pathol. 2000 Jul;157(1):177-87. doi: 10.1016/S0002-9440(10)64529-4.
8
Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction.小鼠纤溶酶原基因的破坏消除了心肌梗死后的伤口愈合。
Am J Pathol. 2000 Jun;156(6):1865-73. doi: 10.1016/S0002-9440(10)65060-2.
9
An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.活化凝血酶激活的纤维蛋白溶解抑制因子抑制剂在兔颈静脉溶栓模型中增强组织型纤溶酶原激活剂诱导的溶栓作用。
Thromb Res. 2000 May 15;98(4):333-42. doi: 10.1016/s0049-3848(00)00184-5.
10
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.凝血酶激活的纤维蛋白溶解抑制剂与深静脉血栓形成风险
Blood. 2000 May 1;95(9):2855-9.